Results for tag: "Translational Biomarker"

Translational biomarkers are biological molecules used to measure the efficacy of a drug or therapy in clinical trials. They are used to assess the safety and efficacy of a drug or therapy in humans, and to predict the likelihood of a successful outcome. Translational biomarkers are used to identify and monitor the progression of diseases, and to assess the effectiveness of treatments. They are also used to identify potential drug targets and to develop personalized treatments. Translational biomarkers are used in a variety of clinical settings, including oncology, neurology, cardiology, and infectious diseases. They are also used in the development of diagnostics and therapeutics. Companies in the translational biomarker market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more